.After antibody-drug conjugate (ADC) specialist Seagen was actually marketed to Pfizer in 2013 for a...
.On the heels of a stage 3 gain that failed to blow away entrepreneurs, Ironwood Pharmaceuticals is ...
.Don't cease Monte Rosa Rehabs right now. The Boston-based biotech is enjoying after authorizing a h...
.Invite to this week's Chutes & Ladders, our summary of substantial leadership hirings, firings a...
.Commemorating his firm's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer rang the...
.AbbVie has returned to the resource of its own antipsychotic powerhouse Vraylar searching for yet a...
.GenSight Biologics is actually weeks off of losing funds. Once again. The biotech only has sufficie...
.Monopar Therapeutics is recovering a medicine coming from the scrap heap of AstraZeneca's rare ailm...
.Along with brand-new data out on Arcus Biosciences' speculative HIF-2a prevention, one team of prof...
.After forming a gene treatment partnership with Dyno Therapies in 2020, Roche is back for more.In a...